What I think AstraZeneca's purchase of Alexion means for the dividend
What I think AstraZeneca’s purchase of Alexion means for the dividend More on: AstraZeneca(LSE:AZN) recently agreed to buy Alexion Pharmaceuticals for around $39bn. Although management has spoken positively about the deal, AstraZeneca shares initially fell 5.7% to a nine-month low on the news. Given the initial market reaction, here’s what I think the deal means for AstraZeneca’s dividend if it goes through: US$12.3 TRILLION out of thin air… And if you click here we’ll show you something that could be key to unlocking 5G’s full potential... The reaction to the Alexion deal Ac...
Source: fool.co.uk